Central Government News

REVISION OF CEILING RATES FOR REIMBURSEMENT OF THE COST OF CARDIAC PACEMAKER, ALCD, COMBO-DEVICE, ROTABLATOR AND AORTIC STENT GRAFT FOR BENEFICIARIES OF CGHS/CS(MA) RULES

Revision of ceiling rates for reimbursement of the cost of Cardiac pacemaker, AlCD, Combo-device, Rotablator and Aortic Stent Graft for beneficiaries of CGHS/CS(MA) Rules.
Government of India
Ministry of Health and Family Welfare
Department of Health & Family Welfare
Directorate General of CGHS
Office of the Director, CGHS
No: S-11011/29/2018-CGHS(HEC)/ DIR/CGHS
Nirman Bhawan, New Delhi
Dated the 6th August, 2018
OFFICE MEMORANDUM
Subject:- Revision of ceiling rates for reimbursement of the cost of Cardiac pacemaker, AlCD, Combo-device, Rotablator and Aortic Stent Graft for beneficiaries of CGHS/CS(MA) Rules.
With reference to the above subject attention is drawn to the OM No 12034/02/2014/Misc./- CGHS D.lll dated 22nd July 2014 vide which ceiling rates for reimbursement of the cost of Cardiac pacemaker, AICD, Combo-device, Rotablator and Aortic Stent Graft for beneficiaries of CGHS/CS (MA) Rules were prescribed and to state that the matter has been reviewed by the Ministry and it is decided to revise the ceiling rates as per the details given under:
Sl.No.Cardiac DeviceCeiling Rate
1Single Chamber Cardiac Pacemaker without Rate ResponseRs.34,840/- + GST
2Single Chamber Cardiac Pacemaker with Rate ResponseRs. 44,9281-+ GST
3Dual Chamber Cardiac PacemakerRs.83,200/-+ GST
4Bi-Ventricular Cardiac PacemakerRs.1,95,000/-+ GST
5Implantable Cardioverter Defibrillator (Single Chamber) (ICD/AICD-Single Chamber)Rs.1,75 786/-4+ GST
6Implantable Cardioverter Defibrillator (Dual Chamber) (ICD/AICD-Single Chamber)Rs. 3,75,000/-+ GST
7Combo Device (CRT-D)Rs, 4.90,000/-+ GST
8Aortic Stent Graft (expandable, bifurcated and including delivery system)Rs. 4,40.960/- + GST
9Rotablator with AdvancerRs.49,920/-+ GST
10Rotablator BurrRs.23,920/-+ GST
2. Other terms and conditions prescribed under OM No 12034/02/2014/Misc./-CGHS D.III dated 22nd July 2014 shall remain unchanged.
3. These rates shall remain valid till the rates for the above devices are notified by National Pharmaceutical Pricing Authority (NPPA).
4. Issued with the concurrence of SS&FA, Ministry of Health & Family Welfare vide CD – No.1295 dated 25.07.2018.
(Dr. Atul Prakash)
Director, CGHS

Comments

Popular posts from this blog

GRANT OF ADDITIONAL HRA TO CAPF PERSONNEL ON THEIR TRANSFER TO NON-FAMILY LOCATIONS IN THE EVENT OF THEIR VACATION OF GOVERNMENT ACCOMMODATION RETAINED BY THEM AFTER 3 YEARS

GRANT OF HONORARIUM FOR DELIVERING LECTURES IN ZONAL TRAINING SCHOOLS/CENTRES

REVISION OF RATES OF DAMAGE FOR UNAUTHORIZED OCCUPATION OF RAILWAY ACCOMMODATION